MRC-Holland MLPA. Description version 52; 22 July 2015

Size: px
Start display at page:

Download "MRC-Holland MLPA. Description version 52; 22 July 2015"

Transcription

1 SALSA MS-MLPA probemix ME028-B2 Prader-Willi/Angelman Lot B2-0413, lot B As compared to version B1 (lot B1-0609), the control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME (PWS) and ANGELMAN SYNDROME (AS) are distinct neurogenetic disorders, both usually caused by chromosomal deletions on chromosome 15q11 or by uniparental disomy. The chromosomal alterations result in an aberrant expression profile of gene loci that are subject to imprinting. Absence of a paternal allele of chromosome 15q11, due to chromosomal deletion or uniparental disomy, results in PWS. The absence of the maternal copy of the same region causes AS. This SALSA MS- probemix ME028 can be used to detect copy number changes, as well as to analyse CpG island methylation of the 15q11 region in a semi-quantitative manner. This SALSA ME028-B2 PWS/AS probemix contains 32 probes specific for sequences in or near the PWS/AS critical region of chromosome 15q11, which can be used to detect copy number changes in this region. Five of these probes are specific for an imprinted sequence and contain a recognition site for the methylation sensitive HhaI enzyme. These five probes can be used for the presence of aberrant methylation patterns in the 15q11 locus, either caused by uniparental disomy or by imprinting defects. For the analysis of results, 14 reference probes for genes located outside the PWS/AS region are present. In addition, two probes are present that will indicate complete digestion by the HhaI enzyme in the methylation quantification reaction. This SALSA MS- probemix can be used to detect aberrant methylation of one or more sequences of the Prader-Willi/Angelman region. Methylation levels can be different for different tissues. Please use DNA derived from the same type of tissue and purified by the same method as reference sample. This SALSA MS- probemix can also be used to detect deletions and duplications of one or more sequences of the 15q11 region in a DNA sample. Heterozygous deletions of probe recognition sequences should give a 35-50% reduced relative peak height of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak height, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Please note that several copy number changes affecting only a part of the 15q11 PWS/AS region have been described in healthy persons. Analysis of parental DNA samples can therefore in some cases be required for correct interpretation of results. SALSA MS- probemixes and reagents are sold by for research purposes and to demonstrate the possibilities of the MLPA technique. They are not CE/FDA certified for use in diagnostic procedures. Purchase of the SALSA MS- test probemixes and reagents includes a limited license to use these products for research purposes. The use of this SALSA MS- probemix and reagents requires a thermocycler with heated lid and sequence type electrophoresis equipment. Different fluorescent PCR primers are available. The MLPA technique has been first described in Nucleic Acid Research 30, e57 (2002). The MS-MLPA method for the detection of both copy numbers and methylation changes was described in Nucleic Acid Research 33, e128 by Nygren et al Related SALSA probemixes ME030 BWS: Contains probes for Beckwith-Wiedemann syndrome. P325 OCA2: Contains probes for each exon of OCA2 with the exception of exon 8. P336 UBE3A: Contains probes for each UBE3A exon. P343 Autism-1: Contains additional probes for UBE3A and the 15q13 region. More information Website : info@mlpa.com (information & technical questions); order@mlpa.com (for orders) Mail : bv; Willem Schoutenstraat 6, 1057 DN Amsterdam, the Netherlands SALSA MS- probemix ME028 Prader-Willi/Angelman Page 1 of 11

2 References for SALSA probemix ME028 Ramsden SC et al. (2010). Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes. BMC Med Genet. 11:70. Bittel DC et al. (2007). Methylation-specific multiplex ligation-dependent probe amplification: analysis of subjects with chromosome 15 abnormalities. Genet Test. 11(4): Dikow N et al. (2007). Quantification of the methylation status of the PWS/AS imprinted region: comparison of two approaches based on bisulfite sequencing and methylation-sensitive MLPA. Mol Cell Probes. 21(3): Procter M et al. (2006). Molecular Diagnosis of Prader-Willi and Angelman Syndromes by Methylation- Specific Melting Analysis and Methylation-Specific Multiplex Ligation-Dependent Probe Amplification. Clin Chem. 52(7): Reference DNA samples Please note that the NIBSC provides an excellent panel of WHO certified genomic DNA samples for Prader Willi and Angelman syndrome: Methylation-specific MLPA Please note that each MS-MLPA reaction generates two samples that need analysis by capillary electrophoresis: one undigested sample for copy number detection and one digested sample for methylation detection. A modification of the MLPA technique, MS-MLPA allows the detection of both copy number changes and unusual methylation levels of different sequences in one simple reaction. MLPA probes for methylation quantification are similar to normal MLPA probes, except that the sequence detected by the MS-MLPA probe contains the sequence recognized by the methylation-sensitive restriction enzyme HhaI. Similar to ordinary MLPA reactions, the MS-MLPA protocol starts with sample DNA denaturation and overnight hybridization. The reaction then is split into two tubes. One tube is processed as a standard MLPA reaction. This reaction provides information on copy number changes. The other tube of the MLPA hybridization reaction is incubated with the methylation-sensitive HhaI endonuclease while simultaneously, the hybridized probes are ligated. Hybrids of (unmethylated) probe oligonucleotides and unmethylated sample DNA are digested by the HhaI enzyme. Digested probes will not be exponentially amplified by PCR and hence will not generate a signal when analysed by capillary electrophoresis. In contrast, if the sample DNA is methylated, the hemimethylated probe-sample DNA hybrids are prevented from being digested by HhaI and the ligated probes will generate a signal. More information about MS-MLPA can be found in the MS-MLPA protocol. Please note that this product can not be used with an alternative protocol in which the genomic DNA is first digested with HhaI, followed by MLPA reactions on both digested and undigested genomic DNA. Digestion control probes The target sequences of the digestion control probes are unmethylated in most blood-derived DNA samples. The signals of the digestion control probes should be gone upon complete digestion by HhaI. Besides the two digestion control probes at 346 and 463 nt, the sequence detected by the 184 nt UBE3A MS-MLPA probe is also unmethylated in most blood-derived DNA samples. A total absence of these three probes in the digested sample therefore indicates a complete digestion by HhaI. The 346 nt probe is the most sensitive to incomplete HhaI digestion; HhaI-digestion can be considered sufficient when less than 10% of the 346 nt digestion control probe signal remains in the digested reaction compared to the undigested reaction. Data analysis The ME028-B2 Prader-Willi/Angelman probemix contains 48 MLPA probes with amplification products between 130 and 480 nt. In addition, it contains 9 control fragments generating an amplification product smaller than 120 nt: four DNA Quantity fragments (Q-fragments) at nt, three DNA Denaturation control fragments (D-fragments) at nt, one X-fragment at 100 nt and one Y-fragment at 105 nt. More information on how to interpret observations on these control fragments can be found in the MLPA protocol. SALSA MS- probemix ME028 Prader-Willi/Angelman Page 2 of 11

3 Please note that the great majority of Prader-Willi and Angelman samples will show a deletion of probes, AND/OR a methylation change of four SNRPN and one NDN MS-MLPA probes. Abnormal copy numbers or methylation changes detected by only one or two probes should be treated with caution. The analysis of MS-MLPA probemixes consists of two parts: 1) determining copy numbers by comparing different undigested samples (all MLPA probemixes), and 2) determining methylation patterns by comparing each undigested sample to its digested counterpart (MS-MLPA probemixes only). The second part is unique for MS-MLPA probemixes and serves to semi-quantify the percentage of methylation within a given sample. 1) Copy number analysis Intra-sample data normalisation For analysis of MLPA results, not the absolute fluorescence values but intra-normalised data are used (relative peak heights). The data generated in the undigested sample should first be normalised intrasample by dividing the signal of each probe by the signal of every reference probe in that sample, thus creating as many ratios per probe as there are reference probes. Subsequently, the median of all these produced ratios per probe should be taken; this is the probe s Normalisation Constant. This Normalisation Constant can then be used for sample to reference sample comparison, both for copy number and digestion determination. Inter-sample normalisation (comparison with reference samples) The final probe ratio, or ploidy status, of each probe in each sample is calculated by dividing a) the Normalisation Constant of each probe obtained on the undigested test sample by b) the average Normalisation Constant of that probe obtained on the undigested reference samples. 2) Methylation analysis - Intra-sample data normalisation For analysis of MLPA results, not the absolute fluorescence values but intra-normalised data are used (relative peak height). The data generated in the digested sample should first be normalised intra-sample by dividing the signal of each probe by the signal of every reference probe in that sample, thus creating as many ratios per probe as there are reference probes. Subsequently, the median of all these produced ratios per probe should be taken; this is the probe s Normalisation Constant. This Normalisation Constant can then be used for sample to reference sample comparison. Methylation analysis (comparison with reference samples) The methylation status of each MS-MLPA probe* in each sample is calculated by dividing a) the Normalisation Constant of each probe obtained on the digested test sample by b) the Normalisation Constant of each MS-MLPA probe obtained on the corresponding undigested sample. Multiplying this value by 100 gives an estimation of the percentage of methylation. Aberrant methylation can then be identified by comparing the methylation status of one or more MS-MLPA probes in the sample in question to that obtained on reference samples. *Notes: An MS-MLPA probe targets a single specific HhaI site in a CpG island; if methylation is absent for a particular CpG-site, this does not necessarily mean that the whole CpG island is unmethylated! With this probemix no discrimination between uniparental disomy and imprinting defects can be made. For this, it is necessary to perform microsatellite analysis in the patient and parents. Aberrant methylation of the 15q11 locus In addition to the large de novo deletions of the 15q11 on the paternal or on the maternal chromosome, PWS or AS can be caused by aberrant methylation of the 15q11 locus. This can be caused either by uniparental disomy or by imprinting defects. Aberrant methylation of the 15q11 locus can be detected by use of the 5 methylation specific MLPA probes detecting sequences in the SNRPN gene and the NDN gene, when compared to results obtained on DNA samples from healthy individuals. Table 5 and Figure 3 contain an overview of the expected copy number changes and methylation profiles in PWS/AS patients with deletions or aberrant methylation. SALSA MS- probemix ME028 Prader-Willi/Angelman Page 3 of 11

4 SNRPN locus The four probes targeting the SNRPN gene are located very close to each other and it is expected that all four probes provide similar results. We recommend using the average, or the median, methylation status of these SNRPN probes to determine to methylation status of the SNRPN locus and to disregard aberrant methylation detected by a single SNRPN MS-MLPA probe. NDN locus Please note that the 419 nt NDN probe has a tendency to overdigest and may seem to be only 30% methylated in DNA samples from healthy persons. We noticed that the percentage of methylation found using this and two alternative NDN probes that we tested varies between individuals. Methylation changes of the NDN probe only may not have any clinical significance. We have been informed that the NDN locus is significantly hypomethylated in chorionic villi (Karin Buiting & Jasmin Beygo, Essen, unpublished results). We therefore recommend interpreting the SNRPN locus methylation only in case of prenatal diagnosis. Data normalisation should be performed within one experiment. Only samples purified by the same method should be compared. Confirmation of most exons deletions and amplifications can be done by e.g. Southern blotting, long range PCR, qpcr, FISH. Note that Coffalyser, the MLPA analysis tool developed at, can be downloaded free of charge from our website This probemix was developed at in collaboration with several European laboratories, represented by K. Buiting (Essen) and S. Ramsden (Manchester). Info/remarks/suggestions for improvement: info@mlpa.com. SALSA MS- probemix ME028 Prader-Willi/Angelman Page 4 of 11

5 Table 1. SALSA MS-MLPA ME028-B2 PWS/AS probemix Length Chromosomal region HhaI Methylated SALSA MLPA probe (nt) Ref. UBE3A SNRPN Other 15q site in blood (%) Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 100 X-fragment: Specific for the X chromosome 105 Y-fragment: Specific for the Y chromosome 130 Reference L q Reference L q SNRPN L02951 CpG island (PWS-SRO) + 50% imprinted 148 Reference L q ٨ TUBGCP L00865 BP1-BP2 region 160 UBE3A L00863 Exon Reference L q MKRN L q SNRPN L13905 CpG island (PWS-SRO) + 50% imprinted 184 UBE3A L04293 Exon 1 + 0% 190 SNRPN L04294 CpG island (PWS-SRO) + 50% imprinted 197 UBE3A L11550 Exon APBA L q Reference L q SNRPN L13907 SNORD116 snorna cluster 220 GABRB L q ATP10A L q ± Reference L q ٨ SNRPN L13090 exon u1b* 244 Reference L p SNRPN L13997 CpG island (PWS-SRO) + 50% imprinted 256 SNRPN L12881 exon u5 (AS-SRO) 264 Reference L q SNRPN L13094 intron u2 278 SNRPN L13383 intron u2 287 ٨ SNRPN L11862 exon u1b 294 SNRPN L13088 SNURF-SNRPN exon UBE3A L13474 Exon Reference L q Reference L q SNRPN L13798 SNORD116 snorna cluster + (100%) 337 Reference L q ๑ Digestion L q26 Digestion Control Probe. Signal <10% upon digestion. + 0% 355 UBE3A L12925 Exon ATP10A L q UBE3A L11548 Exon GABRB L q SNRPN L13519 exon U5 (AS-SRO) 400 SNRPN L11861 SNURF-SNRPN exon ± MAGEL L q ± NDN L q % imprinted 427 Reference L p ٨ NIPA L05755 BP1-BP2 region 445 NDN L q Reference L p # ± Digestion L p22 Digestion Control Probe. No signal upon digestion. + 0% 472 SNRPN L13796 SNORD116 snorna cluster 480 Reference L q23 ٨ BP1-BP2 region and u1b-u1b* region: copy number variation in these regions has been described in healthy individuals. NDN: (1) both NDN probes, especially 445 nt, are affected by denaturation problems. Check the 96 nt D-fragment: if this and one or both NDN probes are lower than the 92 nt fragment, denaturation was incomplete. (2) the 419 nt probe has a tendency to overdigest. The SNORD116 snorna gene cluster was previously named HBII nt: target site contains 2 SNPs which may affect probe signal. In case of a reduced probe signal, sequence the target region! ๑ 346 nt: Digestion control, warns for insufficient digestion. HhaI-digestion can be considered sufficient when <10% of the signal remains in the digested reaction compared to the undigested reaction. SALSA MS- probemix ME028 Prader-Willi/Angelman Page 5 of 11

6 #463 nt: Digestion control, warns for insufficient digestion. Upon digestion, this probe should not give a signal. The target sequence of the 328 nt SNORD116 probe appears to be fully methylated in blood-derived DNA but hypomethylated in fetal DNA (K. Buiting & J. Beygo, pers. communication). We have received various reports of different methylation ratios for this probe also in blood-derived DNA and strongly recommend to use this probe only for copy number analysis, not for methylation analysis. ± This probe is located within, or close to, a very strong CpG island. A low signal of this probe can be due to incomplete sample DNA denaturation, e.g. due to the presence of salt in the sample DNA. The 202 nt APBA2 probe is outside the common PWS/AS region. Size of the region showing aberrant copy number will differ between different PWS/AS patients. More 15q13 probes are available in SALSA MLPA probemix P297 Microdeletion- 2. Table 2. 15q probes arranged according to chromosomal location Length (nt) SALSA MLPA probe Gene HhaI site Distance to p- telomere Chromosomal position Distance to next probe 154 ٨ L00865 TUBGCP5 BP1-BP2 region kb 434 ٨ L05755 NIPA1 BP1-BP2 region kb End of copy number variable region L12922 MKRN Exon kb 409 ± L11839 MAGEL Exon kb L11833 NDN Exon kb 419 ± L13937 NDN Exon kb 287 ٨ L11862 SNRPN Exon u1b 6.2 kb 238 ٨ L13090 SNRPN Exon u1b* 64.9 kb L13383 SNRPN Intron u kb L13094 SNRPN Intron u kb L12881 SNRPN Exon u5 (AS-SRO) 0.6 kb L13519 SNRPN Exon u5 (AS-SRO) 33.8 kb L13997 SNRPN SNRPN CpG island (PWS-SRO) 0.1 kb L13905 SNRPN SNRPN CpG island (PWS-SRO) 0.3 kb L04294 SNRPN SNRPN CpG island (PWS-SRO) 0.3 kb L02951 SNRPN SNRPN CpG island (PWS-SRO) 12.5 kb L13088 SNRPN SNURF-SNRPN exon kb L11861 SNRPN SNURF-SNRPN exon kb L13907 SNRPN SNORD116 snorna cluster 24.4 kb L13796 SNRPN SNORD116 snorna cluster 16.0 kb L13798 SNRPN SNORD116 snorna cluster kb L12925 UBE3A Exon kb L13474 UBE3A Exon kb L00863 UBE3A Exon kb L11550 UBE3A Exon kb L11548 UBE3A Exon kb L04293 UBE3A Exon kb L11846 ATP10A Exon kb L11843 ATP10A Exon kb L09339 GABRB Exon kb L11544 GABRB Exon kb L00867 APBA Exon 14; Outside common kb PWS-AS region 346 # L12924 BLM q26 # Digestion control, warns for insufficient digestion. HhaI-digestion can be considered sufficient when <10% of the signal remains in the digested reaction compared to the undigested reaction. 202 nt APBA2 probe is outside the common PWS/AS region. Size of the region showing aberrant copy number will differ between different PWS/AS patients. More 15q13 probes are available in SALSA MLPA probemix P297 Microdeletion-2. ٨ BP1-BP2 region and u1b-u1b* region: The copy numbers of the TUBGCP5 and NIPA1 genes show variation in some healthy individuals! According to Stefansson, H. et al (2008; Nature 455, ), a deletion of this BP1-BP2 region is present in 0.19% of normal individuals and in 0.55% of schizophrenia patients. More probes for this BP1-BP2 region are in the P211 HSP probemix. The chromosomal order of these probes in the NCBI and BLAT databases is different. We used the order that is mentioned by Jiang et al. (2008) BMC Genomics 9:50. Copy number changes of the exon u1b/u1b* regions have been described in some healthy individuals: SALSA MS- probemix ME028 Prader-Willi/Angelman Page 6 of 11

7 ± This probe is located within, or close to, a very strong CpG island. A low signal of this probe can be due to incomplete sample DNA denaturation, e.g. due to the presence of salt in the sample DNA. 366 nt: target site contains 2 SNPs which may affect probe signal. In case of a reduced probe signal, sequence the target region! The new name for the HBII-85 snorna gene cluster is SNORD116. Deletions within the SNORD116 cluster have been described as cause of Prader-Willi phenotype (Sahoo,T. et al (2008) Nature Genetics 40: ). Additional probes in this region are present in the P343 Autism-1 and P336 UBE3A probemixes. Small deletions in this region might be a rare cause of PWS and will only be of interest when they are not present in parental samples. The target sequence of the 328 nt SNORD116 probe appears to be fully methylated in blood-derived DNA but hypomethylated in fetal DNA (K. Buiting & J. Beygo, pers. communication). We have received various reports of different methylation ratios for this probe also in bloodderived DNA and strongly recommend to use this 328 nt probe only for copy number analysis, not for methylation analysis. The AS-SRO is part of the PWS-AS Imprinting Centre (located upstream of the SNURF-SNRPN gene) and is required for a chromosome to have the maternal pattern of epigenetic modification and gene expression only if the chromosome has an intact PWS-SRO. The PWS-SRO is also part of the PWS-AS IC and is a 4.1kb region that includes the SNRPN promoter. The PWS-SRO is unconditionally required for a chromosome to have the paternal pattern of epigenetic modification and gene expression. Note: Exon numbering used here may differ from literature! Please notify us of any mistakes: info@mlpa.com. Table 3. Location of the SNRPN/UBE3A probes in Genbank Length SALSA MLPA Distance to Location in Genbank Distance to Gene (nt) probe p-telomere NG_ next probe 287 SNRPN L Reverse 6.2 kb 238 SNRPN L kb 278 SNRPN L kb 270 SNRPN L kb 256 SNRPN L kb 391 SNRPN L kb 250 SNRPN L kb 178 SNRPN L kb 190 SNRPN L kb 142 SNRPN L kb 328 SNRPN L kb 294 SNRPN L Reverse 8.3 kb 400 SNRPN L kb 214 SNRPN (SNORD116) L Reverse 24.4 kb 472 SNRPN (SNORD116) L kb 328 SNRPN (SNORD116) L kb 355 UBE3A L Reverse 20.3 kb 301 UBE3A L Reverse 11.1 kb 160 UBE3A L Reverse 4.2 kb 197 UBE3A L Reverse 29.8 kb 373 UBE3A L Reverse 33.5 kb 184 UBE3A L Reverse kb Notes: More UBE3A and 15q13 probes are available in SALSA MLPA probemix P336 UBE3A and in SALSA MLPA probemix P343 Autism-1. Please contact us with suggestions or questions about this probemix: info@mlpa.com. SALSA MS- probemix ME028 Prader-Willi/Angelman Page 7 of 11

8 Table 4. Sequences detected by the ME028-B2 probes Length (nt) Gene Sequences detected by the ME028-B2 probes, with HhaI site 130 CTTN GGCTTCCTTCAAGGCAGAGCTGA-GCTACAGAGGCCCTGTGAGTGGGACGGAGCCG 136 DPYSL4 TGGGCTCTGACGCTGACCTGGTCATA-TGGAACCCCAAGGCCACCAAGATCATCTCTGCCAA 142 SNRPN AGGGGGTGTTGAGCGCAGGT-AGGTGTATAATAGTGACCACTGCGTGGTGGAGCAGGGTAC 148 AATF TAGGTTTCATGTCCTTAGCAAGCTACTGAG-TTTCATGGCACCTATTGACCATACTACAATGAATGATGATGCC 154 TUBGCP5 GGACCAACACTTGTACAGCAGTGATCCATT-GTATGTTCCAGATGACAGGGTTTTGGTTACTGAGACTCAGGTT 160 UBE3A GAAGAAGACTCAGAAGCATCTTCCTCAAGG-ATAGGTGATAGCTCACAGGGAGACAACAATTTGCAAAAATTAG 166 CHEK1 GTCACAGGAGAGAAGGCAATATCCAATATT-TATTTCTGGAGTACTGTAGTGGAGGAGAGCTTTTT 172 MKRN3 CGACATGTGTGGGCTGCAGACCT-TGCACCCCATGGATGCTGCCCAGAGGGAAGAACATAT 178 SNRPN GCCGCTGCTGCAGCGAGTCTGGCGCAGAGT-GGAGCGGCCGCCGGAGATGCCTGACGCATCTGTCTGAG 184 UBE3A GAGATCCGTGTGTCTCCCAAGA-TGGTGGCGCTGGGCTCGGGGTGACTACAGGA 190 SNRPN CCGATGGTATCCTGTCCGCTCGCAT-TGGGGCGCGTCCCCCATCCGCCCCCAACTGTGGT 197 UBE3A GCATCTAATAGAACGCTACTACCACCAGTT-AACTGAGGGCTGTGGAAATGAAGCCTGCACGAATGAG 202 APBA2 CAAAGGGTGTGCCCTCACCACCCACTT-GATTTTTTTCATTTTGCCAAAAAGGGGTATGTCTTTATCAAAG 208 COL2A1 GGACCTTCTGTTCCTGTCTCTTCTGGAACA-TTCTTCTCTGAGCCTGAGACCTCTCTCCTGACAGGGT 214 SNRPN CCTGGTGACCAATGCTGCAGGGTA-GGCTGAAGAGGCTTTCACTGTTTGCCCCGACACC 220 GABRB3 AGGCGGCATTGGCGATACCAGGAA-TTCAGCAATATCCTTTGACAACTCAGGAATCCAGTACAGGAAA 226 ATP10A CATGGATCCTTTGGATTTTGATTCCAG-TTGATCCCTGGAGTAAGGTCCTAACCGGGGT 232 VAT1 GCTGATGCCATGAAACAGATGCAGGAGAA-GAAGAATGTGGGCAAGGTCCTCCTGGTTCCAG 238 SNRPN GTGGCCAGCTCACCACCACCTGA-TGAAAGATACACCACAGGGTGAGAGCATCCTAACAGCAAAC 244 DNAH5 GTTTCAAAGGAAAGTCAGTGCTGTGAAAAT-TGACCTGGAAAAAAGCTGTACCATGCCCTCCTGGCAG 250 SNRPN GAGGGAGCTGGGACCCCTGCA-CTGCGGCAAACAAGCACGCCTGCGCGGCCGC 256 SNRPN CCTTGGTTTGCGGCAGAAGAATCTGCA-TTTCGAACAAGTGCCAGGACTGGTCTGAGGAACACACGTT 264 CYP3A5 GAATTCCAGGGCCCACACCTCTGCCTTTG-TTGGGAAATGTTTTGTCCTATCGTCAGGTGAGTTGCTTGAGCTT 270 SNRPN CAGGGATTTGAGAAGAGGGGATTCAGA-TGACAGAGAACATCCCAAGGGAGAAGCAGAATCCAATATAGAG 278 SNRPN CACAGAGATCTGGGAGAGCTGACTTTGGTGAAA-ATTCTCACCTTGCACAGGCTTGTGTCTGTTTTCCAGAATC 287 SNRPN GACCTTGCCCCCGCAAACCA-CACAGAAGGCTCTGAGCTCAGCTACAGTGGCTGC 294 SNRPN CCTGGTTTTTGCTTGGAATCAGATTCCTCGCTA-CTCCAATATGGCTTTAACCACCTCTTGGTGTCTCAGCTAA 301 UBE3A GAAAATCCTGCAGACTTGAAGAAGCAGTTG-TATGTGGAATTTGAAGGAGAACAAGGAGTTGATGAGGGAGGT 309 NF2 GGCAGATCAGCTGAAGCAGGA-CCTGCAGGAAGCACGCGAGGCGGAGCGAAGAGCCAAGCAG 319 CHEK1 CACGACAAAATGGTCAGGTTTAGAATAGTTGT-TCGTGGTTGAAAGACTTGGATAAATGTGGATGAGATAGAA 328 SNRPN GGTGATGGATACTCCAGGTGGGAATGAGAA-AGCGCCATACATGTGTTGACTTGGTACCCTAAGA 337 DLEU1 AGGAGGTTGTTTGCTGTACTCTCCCTTGT-ACAGTTAGCTGTCTCTAGTGCCTGAATGCACTAATTGTCCTTT 346 # BLM GCGGGGTCGCCGTACAGCGC-CGGGAGGGACGCGTATCTCCAAAGCCCAATCAGAGTC 355 UBE3A GGAGTTCTGGGAAATCGTTCATTCATTTAC-AGATGAACAGAAAAGACTCTTCTTGCAGTTTACAACGGGCACA 366 ATP10A GAGAGGCAGATGAACTGCGACGT-GCTCTGGTGTGTCCTGCTCCTTGTTTGCATGTCT 373 UBE3A CAGGAGAACCTCAGTCTGACGACATTG-AAGCTAGCCGAATGTAAGTGTAACTTGGTTGAGACTGTGG 382 GABRB3 CTGAGCTTTCGGTTGAAGAGGAACATTGGA-TACTTCATTCTTCAGACTTATATGCCCTCTATACTGATAACGA 391 SNRPN GAAGTGGCATATATCCAAGGACAGCCATAA-TATTCCACTTGGCCAAGGCTCTTCTGACAGGCTCATG 400 SNRPN GCGAAGCAACCAGAGCGTGAAGAA-AAGCGGGTTTTGGGTCTGGTGTTGCTGCGTG 409 MAGEL2 GCATTCCTGGAAACCAGCAAGATGCTT-GTCCTGAGGTTTTTGGCCAAGCTCCATAAGAAAGATCCAC 419 NDN CTTGCCAGACGGCGCAGACAT-GTCAGAACAAAGTAAGGATCTGAGCGACCCTAACTTTGCAGCC 427 DPYD CAATATGGAGCTTCCGTTTCTGCCAA-GCCTGAACTACCCCTCTTTTACACTCCTATTGATCTGGTGG 434 NIPA1 CAGTGGCTGTTGGCCAGATTGGAA-ACTTCCTGGCTTACACGGCGGTCCCCACGGTCCTGG 445 NDN GAAGGGTGGGGGTGGGTCATTAT-AGTATTCAGGATTTACAGTGCAGTATTCACGTGTAACTTT 454 SLC6A5 CTGGGGCCCATTCTTAGCTCA-ACACCGCGGGGAGCGTTACAAGAACATGATCGAC 463 # MLH1 CTGCTGAGGTGATCTGGCGCAGA-GCGGAGGAGGTGCTTGGCGCTTCTCAGGCTCCTCCTCT 472 SNRPN TCACCTGCATGCTTCACATCCAGGCCAG-AGTGCCTCTGTTGTACCCTCTGTGTTATGAAGACATA 480 BRIP1 CAACACCTGAGCTCGGGTCATCAGAGAATA-GTGCCTCTAGTCCTCCCCGTTTCAAAACAGAGAAGATGGAAA # Digestion control, warns for insufficient digestion. HhaI-digestion can be considered sufficient when <10% of the signal remains in the digested reaction compared to the undigested reaction. The HhaI sites are marked with grey. Ligation sites are marked with Note: Please notify us of any mistakes: info@mlpa.com. SALSA MS- probemix ME028 Prader-Willi/Angelman Page 8 of 11

9 SALSA MLPA probemix ME028-B2 Prader-Willi/Angelman sample pictures * D y e S i g n a l Size (nt) Figure 1. Capillary electrophoresis pattern of a sample of approximately 50 ng undigested human male control DNA analysed with SALSA MLPA probemix ME028-B2 Prader-Willi/Angelman (lot B2-0413) for the quantification of copy numbers. Arrows indicate the location of the two digestion control probes (open arrows) and the five probes detecting the imprinted 15q11 sequences (closed arrows). * The 184 nt probe indicated is unmethylated in most blood-derived DNA samples D y e S i g n a l * Size (nt) Figure 2. Capillary electrophoresis pattern of a sample of approximately 50 ng digested human male control DNA analysed with SALSA MLPA probemix ME028-B2 Prader-Willi/Angelman (lot B2-0413) to determine the methylation status. Arrows indicate the location of the two digestion control probes (open arrows) and the five probes detecting the imprinted 15q11 sequences (closed arrows). * The 184 nt probe indicated is unmethylated in most blood-derived DNA samples SALSA MS- probemix ME028 Prader-Willi/Angelman Page 9 of 11

10 Table 5. Interpretation of copy number and methylation ratio results PWS Deletion PWS Disomy Reference AS Disomy AS Deletion Genomic situation of the 15q11 region * M_ MM PM PP P_ Copy number Copy number ratio % imprinted 100% 100% 50% 0% 0% Methylation ratio * In this row, the paternal and maternal copies of the 15q11 region are indicated with a P or M, respectively. Next to uniparental disomy, PWS/AS can also be caused by aberrant methylation due to imprinting defects. With the ME028 probemix no discrimination between uniparental disomy and imprinting defects can be made. Figure 3. Simplified schematic representation of results that may be obtained with PWS/AS samples. A cartoon of both copies of chromosome 15 in normal individuals (centre), PWS (left) and AS (right) is included at the top. A white box with a red cross indicates a deletion of the 15q11 region; indicates methylation; and and indicate the maternal and paternal copy (except in PWS/AS UPD samples), respectively. The top row of electropherograms schematically shows undigested samples, which are used for copy number analysis. The example shows three reference probes (,, ), three probes for the 15q11 region without a HhaI site (1, 2, 8), one probe for the 15q11 region with a HhaI site ( ), and one digestion control probe with a HhaI site ( ). Peaks with a reduced height relative to the reference (normal) sample are indicated with blue arrows ( ). A reduced copy number ratio is only present in PWS/AS deletion samples. The bottom row of electropherograms schematically shows the accompanying samples that have been digested with HhaI. Compared to the undigested samples, only probes with a HhaI site are affected (, ). The digestion control ( ) is unmethylated, and disappears from the electropherograms (indicated with *). The peak height of the 15q11 probe with a HhaI site ( ) is reduced relative to the undigested samples in the reference sample and in AS samples, as indicated with a red arrow ( ). In PWS samples, the peak height of this probe is not reduced relative to the undigested samples, as indicated with a red square ( ). SALSA MS- probemix ME028 Prader-Willi/Angelman Page 10 of 11

11 Implemented Changes the following has been altered compared to the previous product description version(s). Version July 2015 (13) - Section about the interpretation of results expanded and clarified, including a new table and figure. - Various minor textual changes. - Various minor layout changes. Version 51 (12) - Extra information about genetic region of certain probes (PWS-SRO) added to Table 1 and 2. Version 50 (12) - Error corrected in description of digestion control probes. - Small textual changes. Version 49 (08) - This product description has been changed to incorporate a new lot (lot number added, new picture included). Version 48 (07) - Warning added in Table 1, 232 nt probe L08267, 409 nt probe L11839, 419 nt probe L13937, and 463 nt probe L Version 47 (05) - Information added about the digestion control probes on page 2 and table 1 and 2. - Information added to the figures about the 184 nt probe. Version 46 (05) - Electropherogram pictures using the new MLPA buffer (introduced in December 2012) added. Version 45 (05) - p2: Remark on the availability of reference DNA samples - p2: Remark on partial digestion of the 346 nt DNA digestion control probe as an indication for incomplete HhaI digestion. Version 44 (05) - Added on page 6: More probes are available in SALSA MLPA probemix P343 Autism. Version 43 (05) - Warning on the 328 nt probe below tables 1 and 2 updated. This probe should only be used for copy number analysis. Version 42 (05) - Product description adapted to a new product version (version number changed, lot number added, small changes in Table 1 and Table 2, new picture included). - Warning about variability updated under table 1 for NDN probes at 419 nt (04027-L13937) and 445 nt (11149-L11833). Version 41 (05) - Interpretation of methylation specific MLPA probes with regard to distinguishing uniparental disomy from imprinting defects has been changed. - Reference of Ramsden et al added. - Warning about SNPs added under table 1 for ATP10A probe at 366 nt. - Warning about variability added under table 1 for NDN probe at 455 nt. - Various minor textual and layout changes. Version 40 (05) - Remark added under table 2 about the role of the AS-SRO in AS. - Name of the HBII-85 snorna gene cluster adapted to the new nomenclature (SNORD116). - Small changes of probe lengths in Table 1, 2 and 3 in order to better reflect the true lengths of the amplification products. Version 39 (04) - Remark added in tables 1 and 2 that exon u5 is part of the AS-SRO. Version 38 (04) - This product description has been changed to incorporate a new lot (lot number added, small changes in Table 1 and Table 2, new picture included). Various minor textual changes on page 1, data analysis has been modified, tables have been numbered and standard symbols have been added under Table 1. SALSA MS- probemix ME028 Prader-Willi/Angelman Page 11 of 11

PRADER WILLI/ANGELMAN

PRADER WILLI/ANGELMAN SALSA MS-MLPA probemix ME028-B2 PRADER WILLI/ANGELMAN Lot B2-0811: As compared to version B1 (lot B1-0609, B1-1108), the 88 and 96 nt control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME

More information

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol. Product Description SALSA MS- Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol. Version C1. For complete product history see page 9. Catalogue numbers: ME028-025R: SALSA

More information

MRC-Holland MLPA. Description version 08; 30 March 2015

MRC-Holland MLPA. Description version 08; 30 March 2015 SALSA MLPA probemix P351-C1 / P352-D1 PKD1-PKD2 P351-C1 lot C1-0914: as compared to the previous version B2 lot B2-0511 one target probe has been removed and three reference probes have been replaced.

More information

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment). SALSA MLPA probemix P343-C3 Autism-1 Lot C3-1016. As compared to version C2 (lot C2-0312) five reference probes have been replaced, one reference probe added and several lengths have been adjusted. Warning:

More information

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 The Mismatch Repair (MMR) system is critical for the maintenance of genomic stability. MMR increases the fidelity of DNA

More information

MRC-Holland MLPA. Description version 14; 28 September 2016

MRC-Holland MLPA. Description version 14; 28 September 2016 SALSA MLPA probemix P279-B3 CACNA1A Lot B3-0816. As compared to version B2 (lot B2-1012), one reference probe has been replaced and the length of several probes has been adjusted. Voltage-dependent calcium

More information

MRC-Holland MLPA. Description version 29; 31 July 2015

MRC-Holland MLPA. Description version 29; 31 July 2015 SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082

More information

MRC-Holland MLPA. Description version 30; 06 June 2017

MRC-Holland MLPA. Description version 30; 06 June 2017 SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0517, C1-0114. As compared to the previous B2 version (lot B2-0813, B2-0912), 11 target probes are replaced or added, and 10 new reference probes are

More information

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted.

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted. mix P169-C2 HIRSCHSPRUNG-1 Lot C2-0915. As compared to version C1 (lot C1-0612), the length of one has been adjusted. Hirschsprung disease (HSCR), or aganglionic megacolon, is a congenital disorder characterised

More information

MRC-Holland MLPA. Description version 12; 13 January 2017

MRC-Holland MLPA. Description version 12; 13 January 2017 SALSA MLPA probemix P219-B3 PAX6 Lot B3-0915: Compared to version B2 (lot B2-1111) two reference probes have been replaced and one additional reference probe has been added. In addition, one flanking probe

More information

SALSA MLPA KIT P050-B2 CAH

SALSA MLPA KIT P050-B2 CAH SALSA MLPA KIT P050-B2 CAH Lot 0510, 0909, 0408: Compared to lot 0107, extra control fragments have been added at 88, 96, 100 and 105 nt. The 274 nt probe gives a higher signal in lot 0510 compared to

More information

MRC-Holland MLPA. Description version 08; 18 November 2016

MRC-Holland MLPA. Description version 08; 18 November 2016 SALSA MLPA probemix P122-D1 NF1 AREA Lot D1-1016. As compared to lot C2-0312, four probes in the NF1 area and one reference probe have been removed, four reference probes have been replaced and several

More information

MRC-Holland MLPA. Description version 18; 09 September 2015

MRC-Holland MLPA. Description version 18; 09 September 2015 SALSA MLPA probemix P090-A4 BRCA2 Lot A4-0715, A4-0714, A4-0314, A4-0813, A4-0712: Compared to lot A3-0710, the 88 and 96 nt control fragments have been replaced (QDX2). This product is identical to the

More information

SALSA MLPA probemix P315-B1 EGFR

SALSA MLPA probemix P315-B1 EGFR SALSA MLPA probemix P315-B1 EGFR Lot B1-0215 and B1-0112. As compared to the previous A1 version (lot 0208), two mutation-specific probes for the EGFR mutations L858R and T709M as well as one additional

More information

MRC-Holland MLPA. Description version 07; 26 November 2015

MRC-Holland MLPA. Description version 07; 26 November 2015 SALSA MLPA probemix P266-B1 CLCNKB Lot B1-0415, B1-0911. As compared to version A1 (lot A1-0908), one target probe for CLCNKB (exon 11) has been replaced. In addition, one reference probe has been replaced

More information

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B1-0613. The purpose of the P372 probemix is to further investigate results found with the P245 Microdeletion Syndromes-1A probemix. The

More information

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced. mix P241-D2 MODY mix 1 Lot D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent diabetes

More information

P323-B1 CDK4-HMGA2-MDM2

P323-B1 CDK4-HMGA2-MDM2 SALSA MLPA probemix P323-B1 CDK4-HMGA2-MDM2 Lot B1-0714, B1-0711. As compared to previous test version (lot A1-0508), this probemix has been completely redesigned. Probes for HMGA2 and several other genes

More information

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced. mix P241-D2 MODY mix 1 Lot D2-0716, D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent

More information

MRC-Holland MLPA. Description version 06; 07 August 2015

MRC-Holland MLPA. Description version 06; 07 August 2015 SALSA MLPA probemix P323-B1 CDK4-HMGA2-MDM2 Lot B1-0711. As compared to version A1 (test version sent to test labs), this product has been completely redesigned. Probes for HMGA2 and several other genes

More information

MRC-Holland MLPA. Description version 19;

MRC-Holland MLPA. Description version 19; SALSA MLPA probemix P6-B2 SMA Lot B2-712, B2-312, B2-111, B2-511: As compared to the previous version B1 (lot B1-11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). SPINAL

More information

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509 mix P371-A1 Microdeletion Syndromes 5 Lot A1-0509 The purpose of the P371 mix is to further investigate results found with the P245 Microdeletion mix. The P245 mix provides a possibility to screen samples

More information

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix. SALSA MLPA KIT P045-B2 BRCA2/CHEK2 Lot 0410, 0609. As compared to version B1, four reference probes have been replaced and extra control fragments at 100 and 105 nt (X/Y specific) have been included. New:

More information

MRC-Holland MLPA. Description version 08; 07 May 2015

MRC-Holland MLPA. Description version 08; 07 May 2015 mix P185-C1 Intersex Lot C1-0611: As compared to the previous version B2 (lot B2-0311), s for CYP21A2 have been removed and s for the CXorf21 gene as well as additional s for NR0B1, NR5A1 and the Y chromosome

More information

MRC-Holland MLPA. Description version 06; 23 December 2016

MRC-Holland MLPA. Description version 06; 23 December 2016 SALSA MLPA probemix P417-B2 BAP1 Lot B2-1216. As compared to version B1 (lot B1-0215), two reference probes have been added and two target probes have a minor change in length. The BAP1 (BRCA1 associated

More information

SALSA MLPA KIT P060-B2 SMA

SALSA MLPA KIT P060-B2 SMA SALSA MLPA KIT P6-B2 SMA Lot 111, 511: As compared to the previous version B1 (lot 11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). Please note that, in contrast to the

More information

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted.

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted. mix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four s have been adjusted. The sex-determining region on chromosome Y (SRY) is the most important

More information

MRC-Holland MLPA. Description version 29;

MRC-Holland MLPA. Description version 29; SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,

More information

MRC-Holland MLPA. Description version 13;

MRC-Holland MLPA. Description version 13; SALSA MLPA probemix P027-C1 Uveal Melanoma Lot C1-0211: A large number of probes have been replaced by other probes in the same chromosomal regions as compared to previous lots, and several reference probes

More information

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53.

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53. SALSA MLPA probemix P056-C1 TP53 Lot C1-0215 & lot C1-0214. As compared to version B1 (lot B1-1011) most of the reference and flanking probes have been replaced and several have been added. Furthermore,

More information

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A1-1011. This SALSA MLPA probemix is for basic research and intended for experienced MLPA users only! This probemix enables you to quantify genes

More information

MRC-Holland MLPA. Description version 23; 15 February 2018

MRC-Holland MLPA. Description version 23; 15 February 2018 SALSA MLPA probemix P225-D2 PTEN Lot D2-0315. As compared to the previous version (lot D1-0613), one probe has a small change in length but no change in the sequence detected. PTEN is a tumour suppressor

More information

MRC-Holland MLPA. Description version 28; 4 January 2018

MRC-Holland MLPA. Description version 28; 4 January 2018 SALSA MLPA probemix ME011-B3 Mismatch Repair genes Lot B3-1017 and B3-0715. As compared to the previous version B2 (lot B2-0614), one probe has a small change in length but no change in the sequence detected.

More information

MRC-Holland MLPA. Description version 05; 03 April 2019

MRC-Holland MLPA. Description version 05; 03 April 2019 SALSA MLPA probemix ME012-A1 MGMT-IDH1-IDH2 Lot A1-1215. Glioblastoma, the most common malignant primary brain tumour, is characterised by aggressive behaviour and a poor survival. Hypermethylation in

More information

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109 SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109 This P078-B1 Breast Tumour probemix contains probes for several genes (including ERBB2, BIRC5, MYC, TOP2A, ESR1, MTDH, CCND1, CCNE1, EGFR and C11orf30)

More information

SALSA MLPA probemix P383-A1 T-ALL Lot A

SALSA MLPA probemix P383-A1 T-ALL Lot A SALSA MLPA probemix P383-A1 T-ALL Lot A1-0213. T-lineage acute lymphoblastic leukaemia (T-ALL) is a clonal malignant disorder of immature T-cells, which accounts for about 15% of paediatric and 25% of

More information

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B1-0916 and B1-0713. Copy number changes of the human chromosome 8 are common in many types of tumours. In most cases, losses of 8p sequences and gains of 8q

More information

MRC-Holland MLPA. Description version 23; 26 January 2017

MRC-Holland MLPA. Description version 23; 26 January 2017 SALSA MLPA probemix ME024-B2 9p21 CDKN2A/2B region Lot B2-0615. As compared to the previous version B1 (lot B1-0411), one flanking probe is redesigned, two reference probes are replaced, and several probes

More information

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length.

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length. SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length. This SALSA probemix is for basic research only! This

More information

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our 1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented

More information

An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice

An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice Mei-Yi Wu 1 *, Ming Jiang 1, Xiaodong Zhai 2, Arthur L. Beaudet 2, Ray-Chang Wu 1 * 1 Department of

More information

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Product Description SALSA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Version C1. As compared to version B3, the probes for the BRCA2 upstream region and exons 8, 11, 12, 19

More information

MRC-Holland MLPA. Description version 15;

MRC-Holland MLPA. Description version 15; probemix P036-E1 HUMAN TELOMERE-3 Lot E1-0910, E1-1208, E1-0808. As compared to version D2 (lot D2-0408), the probes for 1p and 4q have been replaced. Approximately 3-8% of all cases of mental retardation

More information

Epigenetics and Chromatin Remodeling

Epigenetics and Chromatin Remodeling Epigenetics and Chromatin Remodeling Bradford Coffee, PhD, FACMG Emory University Atlanta, GA Speaker Disclosure Information Grant/Research Support: none Salary/Consultant Fees: none Board/Committee/Advisory

More information

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol. Product Description SALSA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol. Version C2. As compared to version C1, three reference probes have been replaced and the lengths of

More information

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol. Product Description SALSA Probemix P055-D1 PAH To be used with the MLPA General Protocol. Version D1. For complete product history see page 7. Catalogue numbers: P055-025R: SALSA MLPA probemix P055 PAH,

More information

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol. Product Description SALSA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol. Version C1. For complete product history see page 7. Catalogue numbers: P138-025R: SALSA MLPA probemix

More information

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol. Product Description SALSA MS- Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol. Version C1. As compared to the previous version (lot B3-1017), this probemix has been

More information

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced.

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced. SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced. MENTAL RETARDATION is caused by aberrant copy numbers of subtelomeric

More information

MRC-Holland MLPA. Description version 10; 06 April 2018

MRC-Holland MLPA. Description version 10; 06 April 2018 Description version ; 6 April 8 mix P36-B Y-Chromosome Microdeletions Lot B-5. As compared to version A (Lot A-), all probes f DPY9L, one probe f RBMYCP and one probe f KDM5D have been removed, and one

More information

MRC-Holland MLPA. Description version 24;

MRC-Holland MLPA. Description version 24; SALSA MLPA KIT P245-A2 Microdeletion Syndromes-1 Lot 0909, 0209, 1008. As compared to lot 1207, two extra control fragments at 100 and 105 nt have been added (X and Y-specific). The 108 nt Y probe has

More information

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol. Product Description SALSA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol. Version F2. Compared to version F1, two reference probes have been replaced and the 118 nt Y fragment has been

More information

UNIQUE DELETIONS IN PRADER-WILLI SYNDROME

UNIQUE DELETIONS IN PRADER-WILLI SYNDROME UNIQUE DELETIONS IN PRADER-WILLI SYNDROME By SOO-JEONG KIM A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF

More information

The Evolving Role of MeCP2 in Rett Syndrome and Autism

The Evolving Role of MeCP2 in Rett Syndrome and Autism ? The Evolving Role of in Rett Syndrome and Autism Janine LaSalle, Ph.D Medical Microbiology and Immunology Rowe Program in Human Genetics UC Davis School of Medicine Epigenetics and Autism What s the

More information

Certificate of Analysis

Certificate of Analysis COA Version 01; Issued on 30 June 2017 (v02) Certificate of Analysis SALSA probemix P064 Microdeletion Syndromes-1B Catalogue # Product name P064-025R, P064-50R, P064-100R Probemix P064 Microdeletion Syndromes-1B

More information

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol. Product Description SALSA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol. Version C2. Small change in sequence of two probes. For complete product history see page

More information

MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experiment

MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experiment (2008) 16, 565 571 & 2008 Nature Publishing Group All rights reserved 1018-4813/08 $30.00 www.nature.com/ejhg ARTICLE MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5

More information

A twin sibling with Prader-Willi syndrome caused by type 2 microdeletion following assisted reproductive technology: A case report

A twin sibling with Prader-Willi syndrome caused by type 2 microdeletion following assisted reproductive technology: A case report 18 A twin sibling with Prader-Willi syndrome caused by type 2 microdeletion following assisted reproductive technology: A case report JI YOON HAN 1, JOONHONG PARK 2,3*, WOORI JANG 2,3*, HYOJIN CHAE 2,3,

More information

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Product Description SALSA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Version C1. As compared to version B3, the probes for the BRCA2 upstream region and exons 8, 11, 12, 19

More information

MLPA SAMPLES USER GUIDE

MLPA SAMPLES USER GUIDE MLPA SAMPLES USER GUIDE MLPA microdeletion studies Requirements: 1-2 mls (minimum) of peripheral blood in a lithium heparin tube (green or orange top) AND 1-2 mls of peripheral blood in a EDTA tube (purple

More information

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant

More information

Quantitative Analysis of SRNPN Gene Methylation by Pyrosequencing as a Diagnostic Test for Prader Willi Syndrome and Angelman Syndrome

Quantitative Analysis of SRNPN Gene Methylation by Pyrosequencing as a Diagnostic Test for Prader Willi Syndrome and Angelman Syndrome Papers in Press. First published March 30, 2006 as doi:10.1373/clinchem.2005.065086 Clinical Chemistry 52:6 000 000 (2006) Molecular Diagnostics and Genetics Quantitative Analysis of SRNPN Gene Methylation

More information

Precise Microdeletion Detection of Prader-Willi Syndrome with Array Comparative Genome Hybridization

Precise Microdeletion Detection of Prader-Willi Syndrome with Array Comparative Genome Hybridization BIOMEDICAL AND ENVIRONMENTAL SCIENCES 23, 194-198 (2010) www.besjournal.com Precise Microdeletion Detection of Prader-Willi Syndrome with Array Comparative Genome Hybridization XIN-YU SHAO a,b, RONG ZHANG

More information

Elucigene Male Factor Infertility Products Guide to Interpretation

Elucigene Male Factor Infertility Products Guide to Interpretation Elucigene Male Factor Infertility Products Guide to Interpretation Manufactured by: Elucigene Diagnostics Citylabs Nelson Street Manchester M13 9NQ For Sales, Customer Service and Technical Support:- T:

More information

Information leaflet for patients and families. Uniparental Disomy (UPD)

Information leaflet for patients and families. Uniparental Disomy (UPD) Information leaflet for patients and families Uniparental Disomy (UPD) What are genes and chromosomes? Our genes are the unique set of instructions inside every cell of our body which make each of us an

More information

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Product Description SALSA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Version D1. As compared to version C2, 12 extra BRCA1 probes and 3 probes for exon 24 have been included, and

More information

LIST OF INVESTIGATIONS

LIST OF INVESTIGATIONS Karyotyping: K001 K002 LIST OF INVESTIGATIONS SAMPLE CONTAINER TYPE cells For Karyotyping [Single] cells For Karyotyping [Couple] Vacutainer Vacutainer 7-8 7-8 K003 Fetal Blood Sample For Karyotyping Vacutainer

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,

More information

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Product Description SALSA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Version D1. For a complete product history see page 11. Catalogue numbers: P002-025R: SALSA MLPA probemix P002

More information

Not IN Our Genes - A Different Kind of Inheritance.! Christopher Phiel, Ph.D. University of Colorado Denver Mini-STEM School February 4, 2014

Not IN Our Genes - A Different Kind of Inheritance.! Christopher Phiel, Ph.D. University of Colorado Denver Mini-STEM School February 4, 2014 Not IN Our Genes - A Different Kind of Inheritance! Christopher Phiel, Ph.D. University of Colorado Denver Mini-STEM School February 4, 2014 Epigenetics in Mainstream Media Epigenetics *Current definition:

More information

High resolution melting for methylation analysis

High resolution melting for methylation analysis High resolution melting for methylation analysis Helen White, PhD Senior Scientist National Genetics Reference Lab (Wessex) Why analyse methylation? Genomic imprinting In diploid organisms somatic cells

More information

CHARACTERIZATION OF THE MURINE ANGELMAN SYNDROME IMPRINTING CENTER

CHARACTERIZATION OF THE MURINE ANGELMAN SYNDROME IMPRINTING CENTER CHARACTERIZATION OF THE MURINE ANGELMAN SYNDROME IMPRINTING CENTER By EMILY YVONNE SMITH A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS

More information

Lab Activity 36. Principles of Heredity. Portland Community College BI 233

Lab Activity 36. Principles of Heredity. Portland Community College BI 233 Lab Activity 36 Principles of Heredity Portland Community College BI 233 Terminology of Chromosomes Homologous chromosomes: A pair, of which you get one from mom, and one from dad. Example: the pair of

More information

CHROMOSOMAL MICROARRAY (CGH+SNP)

CHROMOSOMAL MICROARRAY (CGH+SNP) Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due

More information

Epigenetic mutations in 11p15 in Silver-Russell syndrome are restricted to the telomeric imprinting domain

Epigenetic mutations in 11p15 in Silver-Russell syndrome are restricted to the telomeric imprinting domain JMG Online First, published on October 19, 2005 as 10.1136/jmg.2005.038687 1 Epigenetic mutations in 11p15 in Silver-Russell syndrome are restricted to the telomeric imprinting domain Thomas Eggermann

More information

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits?

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits? corebio II - genetics: WED 25 April 2018. 2018 Stephanie Moon, Ph.D. - GWAS After this class students should be able to: 1. Compare and contrast methods used to discover the genetic basis of traits or

More information

Epigenetics: Basic Principals and role in health and disease

Epigenetics: Basic Principals and role in health and disease Epigenetics: Basic Principals and role in health and disease Cambridge Masterclass Workshop on Epigenetics in GI Health and Disease 3 rd September 2013 Matt Zilbauer Overview Basic principals of Epigenetics

More information

Today. Genomic Imprinting & X-Inactivation

Today. Genomic Imprinting & X-Inactivation Today 1. Quiz (~12 min) 2. Genomic imprinting in mammals 3. X-chromosome inactivation in mammals Note that readings on Dosage Compensation and Genomic Imprinting in Mammals are on our web site. Genomic

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing

More information

Russell-Silver syndrome (RSS)

Russell-Silver syndrome (RSS) GENETIC DIAGNOSTIC LABORATORY Russell-Silver syndrome (RSS) Background: Russell-Silver syndrome (RSS, OMIM 103280, 180860) is a growth disorder characterized by intrauterine and postnatal growth retardation,

More information

Genetics and Genomics in Medicine Chapter 6 Questions

Genetics and Genomics in Medicine Chapter 6 Questions Genetics and Genomics in Medicine Chapter 6 Questions Multiple Choice Questions Question 6.1 With respect to the interconversion between open and condensed chromatin shown below: Which of the directions

More information

CYTOGENETICS Dr. Mary Ann Perle

CYTOGENETICS Dr. Mary Ann Perle CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided

More information

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Application Note Authors John McGuigan, Megan Manion,

More information

National Genetics Reference Laboratory (Wessex) Evaluation of Pyrosequencing for quantitative analysis of CpG methylation at imprinted gene loci:

National Genetics Reference Laboratory (Wessex) Evaluation of Pyrosequencing for quantitative analysis of CpG methylation at imprinted gene loci: National Genetics Reference Laboratory (Wessex) Technology Assessment Evaluation of Pyrosequencing for quantitative analysis of CpG methylation at imprinted gene loci: analysis of SNRPN gene methylation

More information

MODULE NO.14: Y-Chromosome Testing

MODULE NO.14: Y-Chromosome Testing SUBJECT Paper No. and Title Module No. and Title Module Tag FORENSIC SIENCE PAPER No.13: DNA Forensics MODULE No.21: Y-Chromosome Testing FSC_P13_M21 TABLE OF CONTENTS 1. Learning Outcome 2. Introduction:

More information

Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation

Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation Mould et al. Epigenetics & Chromatin 2013, 6:19 RESEARCH Open Access Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation Arne

More information

Clinical evaluation of microarray data

Clinical evaluation of microarray data Clinical evaluation of microarray data David Amor 19 th June 2011 Single base change Microarrays 3-4Mb What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations. Microarray

More information

Bisphenol A Exposure Disrupts Genomic Imprinting in the Mouse

Bisphenol A Exposure Disrupts Genomic Imprinting in the Mouse Bisphenol A Exposure Disrupts Genomic Imprinting in the Mouse Martha Susiarjo 1,2, Isaac Sasson 3, Clementina Mesaros 4, Marisa S. Bartolomei 1,2 * 1 Department of Cell and Developmental Biology, University

More information

The Human Major Histocompatibility Complex

The Human Major Histocompatibility Complex The Human Major Histocompatibility Complex 1 Location and Organization of the HLA Complex on Chromosome 6 NEJM 343(10):702-9 2 Inheritance of the HLA Complex Haplotype Inheritance (Family Study) 3 Structure

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK SW Thames Regional Genetics Laboratory, Jenner Wing, SGUL Cranmer Terrace London SW17 0RE Contact: Mr John Short Tel: +44 (0) 208 725 5332 Fax: +44 (0) 208 725 3440 E-Mail: swtrgl@stgeorges.nhs.uk Website:

More information

When to suspect Prader Willi Syndrome and how to diagnose it?

When to suspect Prader Willi Syndrome and how to diagnose it? When to suspect Prader Willi Syndrome and how to diagnose it? Dr Chirita-Emandi Adela Dr Dobrescu Andreea Victor Babes University of Medicine and Pahrmacy Timisoara Emergency Hospital for Children Louis

More information

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه

More information

Clinical Genomics. Ina E. Amarillo, PhD FACMGG

Clinical Genomics. Ina E. Amarillo, PhD FACMGG Clinical Genomics Ina E. Amarillo, PhD FACMGG Associate Medical Director, Cytogenetics Lab (CaTG), Lab and Genomic Medicine Assistant Professor, Pathology and Immunology Outline Clinical Genomics Testing

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,

More information

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol. Product Description SALSA Probemix P250-B2 DiGeorge To be used with the MLPA ral Protocol. Version B2. As compared to version B1, the control fragments have been adjusted. For complete product history

More information

Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects

Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects (2004) 12, 987 992 & 2004 Nature Publishing Group All rights reserved 1018-4813/04 $30.00 www.nature.com/ejhg ARTICLE : comparison among different classes and between and UPD subjects Monica Castro Varela*,1,

More information

Detection of copy number variations in PCR-enriched targeted sequencing data

Detection of copy number variations in PCR-enriched targeted sequencing data Detection of copy number variations in PCR-enriched targeted sequencing data German Demidov Parseq Lab, Saint-Petersburg University of Russian Academy of Sciences, current: Center for Genomic Regulation

More information

Structural Variation and Medical Genomics

Structural Variation and Medical Genomics Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,

More information

Chromosomes, Mapping, and the Meiosis-Inheritance Connection. Chapter 13

Chromosomes, Mapping, and the Meiosis-Inheritance Connection. Chapter 13 Chromosomes, Mapping, and the Meiosis-Inheritance Connection Chapter 13 Chromosome Theory Chromosomal theory of inheritance - developed in 1902 by Walter Sutton - proposed that genes are present on chromosomes

More information

2001 Oxford University Press Human Molecular Genetics, 2001, Vol. 10, No

2001 Oxford University Press Human Molecular Genetics, 2001, Vol. 10, No 2001 Oxford University Press Human Molecular Genetics, 2001, Vol. 10, No. 26 2989 3000 Tumor development in the Beckwith Wiedemann syndrome is associated with a variety of constitutional molecular 11p15

More information